Archived Insight | July 20, 2022

Roe Overturned: What Employers & Plan Sponsors Need to Know

In the most consequential reproductive rights case in generations, the U.S. Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization has overturned Roe v. Wade. This decision impacts employers and plan sponsors, which now have a number of actions to consider.

Roe Overturned: What Employers & Plan Sponsors Need to Know (1)

On July 20, our national compliance and clinical experts discussed the top employer and plan sponsor concerns including:

  • The decision, impact on multi-state entities and potential ERISA preemption
  • Required changes and strategic decisions impacting health plans, travel benefits, paid leave, fertility coverage and health reimbursement arrangements
  • Pharmaceutical benefits related to pregnancy, such as contraceptives and medication abortion and coordination with pharmacy benefit managers
  • Financial security, dependent and education benefits, communication issues and potential disparate impact on workforce diversity

Watch the Webinar

 

Get the Slides

Don’t have time to watch a video right now? No worries. Here is a copy of the slides.

Download Now

See more insights

Female Nutritionist Holding Image Of Healthy Eating Plate

Health Coaching Enhances Well-Being and Productivity

Your organization can derive significant value from integrating health coaching into its existing health-management programs.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Lawyer And Business Person Discussing In The Office

Supreme Court Addresses Prohibited Transaction Lawsuits

As a result of the Supreme Court’s decision, it will be easier for participants to sue plans for everyday plan transactions with service providers.

Retirement, Compliance, Multiemployer Plans, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Read Full Insight

Pharmacist Taking Inventory With Digital Tablet

Executive Order Seeks to Lower Prescription Drug Prices

The order instructs federal departments to issue regulations or work with Congress to identify statutory changes necessary to address drug prices.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.